Clinical trial
Impact of Neutralizing Antibodies on Interferon Responsive Genes Highlights Biomarker Response.
NCT00288990 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Neutralizing Antibodies on Interferon Responsive Genes Highlights Biomarker Response.
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- August 31, 2007
- Enrollment
- 300 (estimated)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.